• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: David Collier
Institution: Eli Lilly and Company Ltd
Department: Neuroscience
Proposed Analysis: As part of our basic research program into biomarkers in neurodegeneration, we are interested in looking for biomarkers that are associated with disease progression, disease onset, and features of the disease which might indicate different states, such as neuronal loss, neuroinflammation or metabolic disruption. As part of this process, we would like access to The Alzheimer's Disease Metabolomics Consortium (ADMC/ADNI) general metabolomic datasets for the AD research community. These will be used in the context of the accelerating medicines partnership for Alzheimer's disease, with an emphasis on changes in brain lipids and lipid receptors and transporters in the brain that are seen in AD and MCI
Additional Investigators